ArticleFrontiers in microbiology2026
The oral-amplifier hypothesis: linking oral inflammation to intestinal microbial activity in autism spectrum disorder.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The oral-amplifier hypothesis proposes a testable sequence linking oral inflammation to intestinal microbial activity. Gingival or periodontal inflammation may alter the identity and quantity of strains released into saliva. Gastrointestinal conditions may then clear those strains, permit repeated passage, or support local activity. A participant-matched strain is an oral and intestinal population from the same person that meets prespecified genomic, coverage, and contamination criteria. The hypothesis predicts that greater inflammation-associated oral strain output will precede increased abundance or activity of the genomically matched intestinal strain. The lag is calibrated to the participant's measured gastrointestinal transit time. The first proposed study tests this lagged within-person relationship, termed source-to-activity coupling. It asks whether community resistance, mucosal immunity, and local resources modify the relationship's magnitude, delay, or persistence. The second proposed study is a controlled oral-health intervention in which reduced gingival inflammation must accompany a verified reduction in candidate-strain salivary output. It then tests whether matched intestinal activity declines after that verified source reduction. ASD is methodologically informative because oral-care needs, diet, medication exposure, gastrointestinal symptoms, immune state, and transit time may vary together within individuals. This variation provides measurable contrasts for testing oral output and gastrointestinal filtering but does not make the mechanism ASD-specific or causal in ASD. Together, the two proposed studies test whether increased oral output precedes transit-calibrated matched intestinal activity and verified source reduction produces downstream decline. Concordance would support a reversible, strain-specific oral contribution, whereas failure of either temporal pattern would constrain or refute the hypothesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.